Neuropsychologic testing for chemotherapy-related cognitive impairment

Area of Science:

• Neuroscience
• Oncology
• Psychology

Background:

• Chemotherapy-related cognitive impairment (CRCI) lacks standardized diagnostic tools.
• Existing objective neuropsychological tests show poor correlation with patient-reported subjective experiences of cognitive deficits.
• The complexity of CRCI necessitates novel approaches to assessment.

Purpose of the Study:

• To review current challenges in neuropsychological testing for CRCI.
• To highlight the need for incorporating qualitative patient data into test development.
• To advocate for improved methods for identifying and quantifying CRCI.

Main Methods:

• Literature review of existing neuropsychological tests for CRCI.
• Analysis of the limitations of current objective and subjective assessment methods.
• Examination of the role of qualitative research in understanding patient experiences.

Main Results:

• Current neuropsychological tests for CRCI are not standardized.
• A significant gap exists between objective test results and patients' self-reported cognitive difficulties.
• Qualitative data on lived experiences are crucial for understanding CRCI.

Conclusions:

• The development of standardized, accurate tests for CRCI is currently lacking.
• Qualitative patient-reported outcomes are essential for guiding the creation of more effective CRCI assessment tools.
• Further research should focus on integrating subjective experiences into objective CRCI testing.